Finnair's Embraer Order Bolsters Backlog but Leaves Execution Hurdles Unaddressed

What happened

Finnair announced it will renew its European narrow-body fleet with an order for 18 E195-E2 aircraft from Embraer, shifting away from Airbus. This adds to Embraer's already record $31.6 billion firm-order backlog reported in 4Q25, reinforcing the company's demand narrative in a crowded market. However, the DeepValue report emphasizes that Embraer's stock trades at high multiples (P/E 41.6x, EV/EBITDA 14.3x) and is priced for flawless backlog conversion, which remains gated by supply-chain constraints and production leveling efforts. The report identifies key risks, including customer concentration—with E2 backlog heavily reliant on a few airlines and lessors—and the potential for further distress beyond Azul's recent order renegotiation. While the Finnair win is a competitive positive, it does not materially mitigate these execution uncertainties or alter the near-term need for proof in delivery cadence.

Implication

In the short term, the Finnair order provides a modest backlog increment but is too small to significantly impact the $31.6 billion total or change the crowded narrative focused on backlog growth. It highlights Embraer's ability to compete against Airbus in the narrow-body segment, potentially attracting similar orders and boosting investor sentiment. However, the core investment thesis hinges on evidence of production leveling—reducing 4Q delivery bunching—and containing customer distress, which this news does not address. Investors must still watch for 1H26 delivery data to confirm improved throughput and monitor for any additional backlog renegotiations beyond Azul. Given the high valuation and unresolved risks, the stock remains vulnerable to setbacks, reinforcing the cautious stance recommended in the report.

Thesis delta

The Finnair order slightly strengthens the demand side of the thesis by adding to backlog visibility, but it does not shift the assessment of execution risks. The critical watchpoints—production leveling outcomes and potential for more customer renegotiations—remain unchanged, keeping the call at 'WAIT' until 1H26 evidence emerges.